CoChat

Recombinant Adeno-Associated Virus Vectors Induce Functionally Impaired Transgene Product-Specific CD8+ T Cells in Mice

Open access
Lin, Shih-Wen, Hensley, Scott E., Tatsis, Nia, Lasaro, Marcio O., Ertl, Hildegund C.J. · 2007 · Journal of Clinical Investigation

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Abstract

Recombinant adeno-associated virus (rAAV) vectors were used in human trials as carriers of vaccines for HIV-1 after encouraging preclinical results. However, the clinical trials yielded disappointing results. Here we demonstrated that in mice, rAAV vectors expressing the gene encoding HIV-1 gag stimulated gag-specific CD8(+) T cells, but these T cells failed to expand after a booster immunization with a replication-defective adenoviral (Ad) vector also expressing gag. We tested rAAV vectors of different serotypes expressing HIV-1 gag for induction of transgene product-specific CD8(+) T cells and found that the immunoinhibitory effect of rAAV priming observed with different AAV serotypes was transgene product specific, was independent of the interval between prime and boost, and extended to boosts with vaccine modalities other than Ad vectors. rAAV vector-induced CD8(+) T cells proliferated poorly, produced low levels of IFN-gamma in response to gag stimulation, and upregulated immunoinhibitory molecules. These T cells did not protect efficiently against challenge with a surrogate pathogen. Finally, we showed that the impaired proliferative capacity of the T cells was caused by persistence of the antigen-encoding rAAV vectors and could be reversed by placing the CD8(+) T cells in an antigen-free environment. Our data suggest that rAAV vectors induce functionally impaired T cells and could dampen the immune response to a natural infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci33138

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Research works printed but not linked: 2

  1. Steinman, 2006, Curr. Top. Microbiol. Immunol., 311, 17
  2. van Lunzen, J., et al. 2007. A Phase I study to evaluate the safety and immunogenicity of a recombinant adeno-associated virus vaccine. In 14th Conference on Retroviruses and Opportunistic Infections. February 25–28, 2007. Los Angeles, California, USA. Foundation for Retrovirology and Human Health. http://www.retroconference.org/2007.

Cited by

See all 88

Metadata

Authors
Lin, S.-W., Hensley, S. E., Tatsis, N., Lasaro, M. O., & Ertl, H. C. J.
Affiliations
The Wistar Institute (US)
Corresponding author
Ertl, Hildegund C.J.
Venue
Journal of Clinical Investigation
Published
2007-11-15
Volume
117
Issue
12
Pages
3958-70
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2164754609
Cited by
88
References
75
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2021: 2 · 2020: 2 · 2019: 5 · 2018: 2 · 2017: 7 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 6 · 2012: 5
FWCI
5.71
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Pennsylvania
  • National Institutes of Health
  • U.S. Public Health Service (P01 A1055018-02)
  • National Heart, Lung, and Blood Institute (P01HL078810)
  • National Institute of Allergy and Infectious Diseases
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
recombinant adeno-associated virus vectors, HIV-1 Gag, CD8+ T cells, T cell proliferation, interferon-gamma, AAV serotypes, prime-boost vaccination, HIV-1 vaccine, antigen persistence, T cell dysfunction, vaccine immunogenicity
MeSH terms
Dependovirus, Adenoviridae, Animals, Genetic Vectors, Humans, Immunization, Secondary, Mice, Inbred BALB C, HIV-1, AIDS Vaccines, CD8-Positive T-Lymphocytes, Transgenes, Cell Proliferation, Mice, gag Gene Products, Human Immunodeficiency Virus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recombinant Adeno-Associated Virus Vectors Induce Functionally Impaired Transgene Product-Specific CD8+ T Cells in Mice. https://app.cochat.ai/papers/10.1172/jci33138
The paper
Lin, S.-W., Hensley, S. E., Tatsis, N., Lasaro, M. O., & Ertl, H. C. J. (2007). Recombinant Adeno-Associated Virus Vectors Induce Functionally Impaired Transgene Product-Specific CD8+ T Cells in Mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci33138

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.